The failure of preoperative ethylene-vinyl alcohol copolymer embolization to improve outcomes in arteriovenous malformation management: case series

Clinical article

View More View Less
  • 1 Department of Neurosurgery, Australian School of Advanced Medicine;
  • 2 Macquarie University Library; and
  • 3 Macquarie University Hospital, Macquarie University, Sydney, New South Wales, Australia
Restricted access

Purchase Now

USD  $45.00

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00
Print or Print + Online

Object

Ethylene-vinyl alcohol copolymer embolization is increasingly used preoperatively in the resection of brain arteriovenous malformations (AVMs). However, the case for embolization improving the outcome of resection has not been evaluated. In this paper the authors set out to compare outcomes after surgery for brain AVMs in 2 consecutive periods of practice. In the first period, selective embolization was used without the use of ethylene-vinyl alcohol copolymer. In the second period, selective embolization with ethylene-vinyl alcohol copolymer was performed.

Methods

A consecutive case series (prospectively collected data) was retrospectively analyzed. Adverse outcomes were considered to be an outcome modified Rankin Scale score greater than 2 due to embolization or surgery.

Results

A total of 538 surgical cases were included. The percentages of adverse outcomes were as follows: 0.34% for Spetzler-Martin AVMs less than Grade III (1 of 297 cases); 5.23% (95% CI 2.64%–9.78%) for Grade III AVMs (9 of 172 cases); and 17% (95% CI 10%–28%) for AVMs greater than Grade III (12 of 69 cases). There was no improvement in outcomes from the first period to the second period. The adverse outcome for Grade III brain AVMs in the first period was 5.2% (7 of 135 cases) and in the second period (after ethylene-vinyl alcohol copolymer was introduced) it was 5.4% (2 of 37 cases). For AVMs greater than Grade III, the adverse outcome was 12% (6 of 49 cases) in the first period and 30% (6 of 20 cases) in the second period.

Conclusions

Outcomes for brain AVM surgery were not improved by ethylene-vinyl alcohol copolymer embolization. Preoperative embolization of high-grade AVMs with an ethylene-vinyl alcohol copolymer did not prevent those hemorrhagic complications which embolization is hypothesized to prevent based on theoretical speculations but not demonstrated in practice.

Abbreviations used in this paper:AVM = arteriovenous malformation; EVACE = ethylene-vinyl alcohol copolymer embolization; GOS = Glasgow Outcome Scale; mRS = modified Rankin Scale.

JNS + Pediatrics - 1 year subscription bundle (Individuals Only)

USD  $505.00

JNS + Pediatrics + Spine - 1 year subscription bundle (Individuals Only)

USD  $600.00

Contributor Notes

Address correspondence to: Michael K. Morgan, M.D., Health and Medical Development, Macquarie University, 2 Technology Place, Sydney, New South Wales 2109, Australia. email: michael.morgan@mq.edu.au.

Please include this information when citing this paper: published online January 25, 2013; DOI: 10.3171/2012.11.JNS112064.

  • 1

    Agresti A, & Coull BA: Approximate is better than “exact” for interval estimation of binomial proportions. Am Stat 52:119126, 1998

  • 2

    Al-Shahi R, , Bhattacharya JJ, , Currie DG, , Papanastassiou V, , Ritchie V, & Roberts RC, : Prospective, population-based detection of intracranial vascular malformations in adults: the Scottish Intracranial Vascular Malformation Study (SIVMS). Stroke 34:11631169, 2003

    • Search Google Scholar
    • Export Citation
  • 3

    ApSimon HT, , Reef H, , Phadke RV, & Popovic EA: A population-based study of brain arteriovenous malformation: long-term treatment outcomes. Stroke 33:27942800, 2002

    • Search Google Scholar
    • Export Citation
  • 4

    Atkinson RP, , Awad IA, , Batjer HH, , Dowd CF, , Furlan A, & Giannotta SL, : Reporting terminology for brain arteriovenous malformation clinical and radiographic features for use in clinical trials. Stroke 32:14301442, 2001

    • Search Google Scholar
    • Export Citation
  • 5

    Davidson AS, & Morgan MK: How safe is arteriovenous malformation surgery? A prospective, observational study of surgery as first-line treatment for brain arteriovenous malformations. Neurosurgery 66:498505, 2010

    • Search Google Scholar
    • Export Citation
  • 6

    Farrell B, , Godwin J, , Richards S, & Warlow C: The United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: final results. J Neurol Neurosurg Psychiatry 54:10441054, 1991

    • Search Google Scholar
    • Export Citation
  • 7

    Frizzel RT, & Fisher WS III: Cure, morbidity, and mortality associated with embolization of brain arteriovenous malformations: a review of 1246 patients in 32 series over a 35-year period. Neurosurgery 37:10311040, 1995

    • Search Google Scholar
    • Export Citation
  • 8

    Gabriel RA, , Kim H, , Sidney S, , McCulloch CE, , Singh V, & Johnston SC, : Ten-year detection rate of brain arteriovenous malformations in a large, multiethnic, defined population. Stroke 41:2126, 2010

    • Search Google Scholar
    • Export Citation
  • 9

    Gao K, , Yang XJ, , Mu SQ, , Li YX, , Zhang YP, & M, : Embolization of brain arteriovenous malformations with ethylene vinyl alcohol copolymer: technical aspects. Chin Med J (Engl) 122:18511856, 2009

    • Search Google Scholar
    • Export Citation
  • 10

    Hamada J, , Kai Y, , Morioka M, , Kazekawa K, , Ishimaru Y, & Iwata H, : A mixture of ethylene vinyl alcohol copolymer and ethanol yielding a nonadhesive liquid embolic agent to treat cerebral arteriovenous malformations: initial clinical experience. J Neurosurg 97:881888, 2002

    • Search Google Scholar
    • Export Citation
  • 11

    Hauck EF, , Welch BG, , White JA, , Purdy PD, , Pride LG, & Samson D: Preoperative embolization of cerebral arteriovenous malformations with onyx. AJNR Am J Neuroradiol 30:492495, 2009

    • Search Google Scholar
    • Export Citation
  • 12

    Katsaridis V, , Papagiannaki C, & Aimar E: Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology 50:589597, 2008

    • Search Google Scholar
    • Export Citation
  • 13

    Loh Y, & Duckwiler GR: A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg 113:733741, 2010

    • Search Google Scholar
    • Export Citation
  • 14

    Luessenhop AJ, & Spence WT: Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation. JAMA 172:11531155, 1960

    • Search Google Scholar
    • Export Citation
  • 15

    Maimon S, , Strauss I, , Frolov V, , Margalit N, & Ram Z: Brain arteriovenous malformation treatment using a combination of Onyx and a new detachable tip microcatheter, SONIC: short-term results. AJNR Am J Neuroradiol 31:947954, 2010

    • Search Google Scholar
    • Export Citation
  • 16

    Morgan MK, Classification and decision making in treatment and perioperative management, including surgical and radiosurgical decision making. Winn HR: Youmans Neurological Surgery ed 5 Philadelphia, Saunders, 2004. 2:21852204

    • Search Google Scholar
    • Export Citation
  • 17

    Morgan MK, , Rochford AM, , Tsahtsarlis A, , Little N, & Faulder KC: Surgical risks associated with the management of Grade I and II brain arteriovenous malformations. Neurosurgery 61:1 Suppl 417424, 2007

    • Search Google Scholar
    • Export Citation
  • 18

    Morgan MK, , Winder M, , Little NS, , Finfer S, & Ritson E: Delayed hemorrhage following resection of an arteriovenous malformation in the brain. J Neurosurg 99:967971, 2003

    • Search Google Scholar
    • Export Citation
  • 19

    Morgan MK, , Zurin AAR, , Harrington T, & Little N: Changing role for preoperative embolisation in the management of arteriovenous malformations of the brain. J Clin Neurosci 7:527530, 2000

    • Search Google Scholar
    • Export Citation
  • 20

    Mounayer C, , Hammami N, , Piotin M, , Spelle L, , Benndorf G, & Kessler I, : Nidal embolization of brain arteriovenous malformations using Onyx in 94 patients. AJNR Am J Neuroradiol 28:518523, 2007

    • Search Google Scholar
    • Export Citation
  • 21

    Newcombe RG: Two-sided confidence intervals for the single proportion: comparison of seven methods. Stat Med 17:857872, 1998

  • 22

    Panagiotopoulos V, , Gizewski E, , Asgari S, , Regel J, , Forsting M, & Wanke I: Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). AJNR Am J Neuroradiol 30:99106, 2009

    • Search Google Scholar
    • Export Citation
  • 23

    Pasqualin A, , Scienza R, , Cioffi F, , Barone G, , Benati A, & Beltramello A, : Treatment of cerebral arteriovenous malformations with a combination of preoperative embolization and surgery. Neurosurgery 29:358368, 1991

    • Search Google Scholar
    • Export Citation
  • 24

    Pierot L, , Januel AC, , Herbreteau D, , Barreau X, , Drouineau J, & Berge J, : Endovascular treatment of brain arteriovenous malformations using onyx: results of a prospective, multicenter study. J Neuroradiol 36:147152, 2009

    • Search Google Scholar
    • Export Citation
  • 25

    Rankin J: Cerebral vascular accidents in patients over the age of 60. II. Prognosis. Scott Med J 2:200215, 1957

  • 26

    Ross J, & Al-Shahi Salman R: Interventions for treating brain arteriovenous malformations in adults. Cochrane Database Syst Rev 2010:CD003436, 2010

    • Search Google Scholar
    • Export Citation
  • 27

    Saatci I, , Geyik S, , Yavuz K, & Cekirge HS: Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. Clinical article. J Neurosurg 115:7888, 2011

    • Search Google Scholar
    • Export Citation
  • 28

    Stapf C, , Mast H, , Sciacca RR, , Berenstein A, , Nelson PK, & Gobin YP, : The New York Islands AVM Study: design, study progress, and initial results. Stroke 34:e29e33, 2003

    • Search Google Scholar
    • Export Citation
  • 29

    Starke RM, , Lavine SD, , Meyers PM, & Connolly ES Jr, Adjuvant endovascular management of brain arteriovenous malformations. Winn HR: Youmans Neurological Surgery ed 6 Philadelphia, Elsevier, 2011. 4:40494064

    • Search Google Scholar
    • Export Citation
  • 30

    UK-TIA Study Group: United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: interim results. Br Med J (Clin Res Ed) 296:316320, 1988

    • Search Google Scholar
    • Export Citation
  • 31

    van Rooij WJ, , Sluzewski M, & Beute GN: Brain AVM embolization with Onyx. AJNR Am J Neuroradiol 28:172178, 2007

  • 32

    Viñuela F, , Dion JE, , Duckwiler G, , Martin NA, , Lylyk P, & Fox A, : Combined endovascular embolization and surgery in the management of cerebral arteriovenous malformations: experience with 101 cases. J Neurosurg 75:856864, 1991

    • Search Google Scholar
    • Export Citation
  • 33

    Weber W, , Kis B, , Siekmann R, & Kuehne D: Endovascular treatment of intracranial arteriovenous malformations with onyx: technical aspects. AJNR Am J Neuroradiol 28:371377, 2007

    • Search Google Scholar
    • Export Citation
  • 34

    Xu F, , Ni W, , Liao Y, , Gu Y, , Xu B, & Leng B, : Onyx embolization for the treatment of brain arteriovenous malformations. Acta Neurochir (Wien) 153:869878, 2011

    • Search Google Scholar
    • Export Citation

Metrics

All Time Past Year Past 30 Days
Abstract Views 256 117 6
Full Text Views 113 3 0
PDF Downloads 100 3 0
EPUB Downloads 0 0 0